Ligand Pharmaceuticals
LGND
#4083
Rank
S$3.05 B
Marketcap
$161.76
Share price
-2.21%
Change (1 day)
115.59%
Change (1 year)

Ligand Pharmaceuticals (LGND) - P/B ratio

P/B ratio as of November 2024 : 2.94

According to Ligand Pharmaceuticals's latest financial reports the company has a price-to-book ratio of 17.0922.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.

Ligand Pharmaceuticals - P/B ratio (from 2001 to 2024)

P/B ratio by year

Year P/B ratio Change
2024-12-31N/A-100%
2023-12-311.78-5.93%
2022-12-311.89-39.92%
2021-12-313.1439.46%
2020-12-312.25-1.43%
2019-12-312.29-54.48%
2018-12-315.02-27.23%
2017-12-316.9020.55%
2016-12-315.73-26.69%
2015-12-317.81-81.7%
2014-12-3142.796.65%
2013-12-3121.730.23%
2012-12-3116.7-41.6%
2011-12-3128.5-179.5%
2010-12-31-35.9-153.08%
2009-12-3167.6-369.41%
2008-12-31-25.1-260.47%
2007-12-3115.6-60.73%
2006-12-3139.8-639.8%
2005-12-31-7.38-34.58%
2004-12-31-11.3-60.61%
2003-12-31-28.6-652.3%
2002-12-315.18

P/B ratio for similar companies or competitors

Company P/B ratio P/B ratio differencediff. Country
21.3 625.15%๐Ÿ‡บ๐Ÿ‡ธ USA
7.89 167.98%๐Ÿ‡บ๐Ÿ‡ธ USA
4.09 38.95%๐Ÿ‡ฌ๐Ÿ‡ง UK
5.60 90.16%๐Ÿ‡บ๐Ÿ‡ธ USA
1.60-45.51%๐Ÿ‡บ๐Ÿ‡ธ USA
54.3 1,744.43%๐Ÿ‡บ๐Ÿ‡ธ USA
6.96 136.47%๐Ÿ‡บ๐Ÿ‡ธ USA
2.24-23.92%๐Ÿ‡บ๐Ÿ‡ธ USA
5.24 77.99%๐Ÿ‡บ๐Ÿ‡ธ USA